Transgene Biotek

quarterly
yearly
ParticularsSep '21Dec '21Mar '22Jun '22Sep '22
Revenue0.010.000.080.060.00
Expenses2.592.632.651.441.77
EBITDA-2.58-2.63-2.57-1.38-1.77
EBIT-5.05-5.10-5.08-2.62-3.01
Profit Before Tax-2.60-2.64-2.55-1.39-1.77
Net Profit-2.60-2.64-2.55-1.39-1.77
Financial Ratios
Operating Profit Margin-25,900%NA%-3,212%-2,317%NA%
Net Profit Margin-26,000%NA%-3,187%-2,317%NA%
Earning Per Share (Diluted)-0.34-0.35-0.33-0.18-0.23
Dividends Per ShareNANANANANA
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.5.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI